Lisata Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for LSTA, updated each market day.
LSTA AI Sentiment
AI sees no strong directional signal for Lisata Therapeutics, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Lisata Therapeutics, Inc. Common Stock
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
Sector
Exchange
Market Cap
$45,161,455
Cap Tier
Employees
21
Headquarters
BASKING RIDGE, NJ
Listed Since
March 1, 1999
Website
LSTA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
LSTA Volatility
Lisata Therapeutics, Inc. Common Stock has shown low price volatility over the last 5 trading days. Low volatility suggests steady price action with smaller daily moves.
